Ownership history in MORGAN STANLEY · 24 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in INNATE PHARMA S A (IPHA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 46,394 | -7,170 | -13.4% | 0.00% | $81K | $1.75 |
| 2025 Q3 | ADDED | 53,564 | +2,340 | +4.6% | 0.00% | $103K | $1.93 |
| 2025 Q2 | ADDED | 51,224 | +7,700 | +17.7% | 0.00% | $93K | $1.82 |
| 2025 Q1 | UNCHANGED | 43,524 | — | 0% | 0.00% | $77K | $1.78 |
| 2024 Q4 | UNCHANGED | 43,524 | — | 0% | 0.00% | $80K | $1.84 |
| 2024 Q3 | UNCHANGED | 43,524 | — | 0% | 0.00% | $100K | $2.29 |
| 2024 Q2 | REDUCED | 43,524 | -600 | -1.4% | 0.00% | $84K | $1.94 |
| 2024 Q1 | REDUCED | 44,124 | -2,230 | -4.8% | 0.00% | $127K | $2.88 |
| 2023 Q4 | ADDED | 46,354 | +1,400 | +3.1% | 0.00% | $130K | $2.80 |
| 2023 Q3 | REDUCED | 44,954 | -2,095 | -4.5% | 0.00% | $114K | $2.53 |
As of 2025 Q4 — sorted by position size